Loading...
Loading...
Oxford Immunotec Global PLC
OXFD announced
today that its initial public offering of 5,360,000 ordinary shares
priced at $12.00 per share. The Company has granted the underwriters the
option to purchase up to an additional 804,000 ordinary shares at the
initial public offering price less the underwriting discount. The
ordinary shares are expected to begin trading on The NASDAQ Global
Market on November 22, 2013 under the trading symbol "OXFD."
J.P. Morgan Securities LLC and Piper Jaffray & Co. are acting as joint
book-running managers for the offering. Cowen and Company, LLC and
Robert W. Baird & Co. Incorporated are acting as co-managers.
A registration statement relating to
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in